[TimChallenge] yea i was looking at CRSP aka Crispr therapeutics, gene editing company... just like EDIT lol

[TimAlerts] NTLA, a long-term play, price is a little high around $21 (08/26/2016). The product used by gene-editing researchers like: https://genome.duke.edu/news/tue-08162016-0918/gersbach-lab-study-directly-converts-mouse-fibroblasts-neuronal-cells-crispr. Compare it to EDIT. I have no position right now, but if it goes to the range between 18 and 20, I plan to buy and hold till 2017 or even till 2020. IT IS A LONG TERM INVESTMENT IDEA, Not a day-trading, Not a short-term trading.

[TimChallenge] Anyone have any CRISPR plays other than EDIT??

[TimAlerts] NTLA hell of an IPO, possible EDIT short over the weekend for competition?

[TimAlerts] NTLA ipo opened 10 minutes ago -- 22.10 - another CRISPR biotech company, like EDIT

[TimAlerts] out EDIT 28.30 average.

[TimAlerts] Long EDIT starter position 27.60$ average.

[TimAlerts] shorted EDIT @ 16.20 - it is spiking for good news of an investment but that's about it

[TimAlerts] EDIT is rocking today

[TimAlerts] EDIT ipo open